There are 2789 resources available
550P - Initial results of a phase Ia/Ib study of NGM120, a first-in-class anti-GDNF family receptor alpha like (GFRAL) antibody in patients (pts) with advanced solid tumors
Presenter: Rishi Jain
Session: ePoster Display
551P - Chronological improvement in precision oncology implementation in Japan
Presenter: Keigo Komine
Session: ePoster Display
552P - Reasons of screening failure during the 28-day screening period in patients identified for inclusion in phase I trials and their outcome
Presenter: Iphigenie Korakis
Session: ePoster Display
553P - Innovative medicinal products and early access provision: Challenges and opportunities to improve access to care for oncology patients
Presenter: Andriy Krendyukov
Session: ePoster Display
554P - Phase I clinical trial of OBP-301, a novel telomerase-specific oncolytic virus, in combination with radiotherapy in esophageal cancer patients
Presenter: Shunsuke Tanabe
Session: ePoster Display
555TiP - A first-in-human trial of the integrin beta-6-targeted antibody–drug conjugate, SGN-B6A, in patients with advanced solid tumors
Presenter: Emiliano Calvo
Session: ePoster Display
556TiP - A phase I study of SGN-STNV, a novel antibody–drug conjugate targeting sialyl-thomsen-nouveau antigen (STn), in adults with advanced solid tumors (SGNSTNV-001)
Presenter: Nehal Lakhani
Session: ePoster Display
557TiP - SGNTUC-019: Phase II basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations
Presenter: Martin Reck
Session: ePoster Display
558TiP - Phase I study of effector-function enhanced monoclonal antibody (mAb), SEA-TGT, in advanced malignancies
Presenter: Vincent Ribrag
Session: ePoster Display
559TiP - A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN inactivating mutations
Presenter: Jordi Rodon
Session: ePoster Display